首页> 外文期刊>Modern Pathology >Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors
【24h】

Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors

机译:复发新型HMGA2-Ncor2融合表征角蛋白阳性细胞富含细胞的软组织肿瘤的子集

获取原文
       

摘要

Giant cell tumors of soft tissue (GCT-ST) are rare low-grade neoplasms that were at one time thought to represent the soft tissue counterparts of GCT of bone (GCT-B) but are now known to lack the H3F3 mutations characteristic of osseous GCT. We present six distinctive giant cell-rich soft tissue neoplasms that expressed keratins and carried a recurrent HMGA2-NCOR2 gene fusion. Patients were five females and one male aged 14-60 years (median, 29). All presented with superficial (subcutaneous) masses that were removed by conservative marginal (3) or wide (2) local excision. The tumors originated in the upper extremity (2), lower extremity (2), head/neck (1), and trunk (1). Five patients with follow-up (median, 21 months; range, 14-168) remained disease-free. Grossly, all tumors were well-demarcated but not encapsulated with variable lobulation. Histologically, they were composed of bland plump epithelioid or ovoid to spindled mononuclear cells admixed with evenly distributed multinucleated osteoclast-type giant cells. Foci of stromal hemorrhage and hemosiderin were seen in all cases. The mitotic activity ranged from 2 to 14/10 high power fields (median: 10). Foci of necrosis and vascular invasion were seen in one case each. The mononuclear cells were immunoreactive with the AE1/AE3 keratin cocktail and less frequently/less diffusely for K7 and K19 but lacked expression of other lineage-associated markers. RNA-based next-generation sequencing revealed an HMGA2-NCOR2 fusion in all tumors. None of the keratin-negative conventional GCT-ST showed the HMGA2-NCOR2 fusion (0/7). Metaplastic bone (4/9) and SATB2 expression (3/4) were frequent in keratin-negative conventional GCT-ST but were lacking in keratin-positive HMGA2-NCOR2 fusion-positive tumors. The distinctive immunophenotype and genotype of these tumors strongly suggest that they represent a discrete entity, differing from conventional GCT-ST and other osteoclast-rich morphologic mimics. Their natural history appears favorable, although a study of additional cases and longer follow-up are warranted.
机译:软组织(GCT-ST)的巨细胞肿瘤是罕见的低级肿瘤,其一次认为代表骨骼的GCT(GCT-B)的软组织对应物,但现在已知缺乏骨质的H3F3突变特征GCT。我们呈现六种独特的巨型细胞富含细胞的软组织肿瘤,表达角蛋白并进行了反复性HMGA2-Ncor2基因融合。患者是五名女性,一个男性14-60岁(中位数,29岁)。所有呈现出浅表(皮下)质量,由保守的边缘(3)或宽(2)局的局部切除除去。肿瘤起源于上肢(2),下肢(2),头部/颈部(1)和躯干(1)。五名随访(中位数,21个月;范围,14-168)仍然无病。严重,所有肿瘤均匀划分,但不封装可变裂解。组织学上,它们由与均匀分布的多核骨细胞型巨细胞混合的Bland Plump上皮细胞或卵侧链。在所有情况下都观察到基质出血和血液素的焦点。有丝分裂活动的范围从2到14/10个高功率场(中位数:10)。每一个案例都可以看到坏死和血管入侵的病灶。单核细胞与AE1 / AE3角蛋白鸡尾酒的免疫反应,较少/较少漫射的K7和K19但缺乏其他谱系相关标记的表达。基于RNA的下一代测序显示所有肿瘤中的HMGA2-Ncor2融合。角蛋白 - 阴性常规GCT-ST都没有显示HMGA2-Ncor2融合(0/7)。在角蛋白 - 阴性常规GCT-ST中频繁出现细胞塑料骨(4/9)和SATB2表达(3/4),但缺乏角蛋白阳性HMGA2-Ncor2融合阳性肿瘤。这些肿瘤的独特免疫蛋白酶型和基因型强烈表明它们代表了离散实体,与常规的GCT-ST和其他富含骨质醛的形态模拟有不同的不同。他们的自然历史似乎有利,尽管有必要研究额外的案例和更长的随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号